Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04524338 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Longitudinal Study Examining At-Home tDCS

StatusRecruiting
PhaseNot applicable
Started2021-02-22
View on ClinicalTrials.gov ↗

Amendment history

2024-08-09
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2022-10-31→2026-10-31
Completion date2022-10-31→2026-10-31
Start dateestimated 2020-10-31→confirmed 2021-02-22
Study sites0→1
2020-08-24
minor
Study Status, Outcome Measures v1
Re-verified, no change to tracked fields
2020-08-20
minor
Original filing
Participants with dementia have reported improvements after receiving tDCS in a study at our lab. Although we make an effort to enroll such participants in further tDCS research studies, some participants are ineligible for further studies or simply unwilling to continue being a research participant. These same individuals, however, are interested in purchasing their own tDCS machine and have approached us for advice on how to purchase their own machine. Because these devices are commercially available, there is nothing theoretically stopping these participants from purchasing their own machine. Therefore, we have chosen to carry out a longitudinal study that will allow us to serve as an advisory role for participants who have decided to continue administering tDCS at home. We will recommend the tDCS related items that should be purchased, and train participants on how to properly administer tDCS. Monthly reports will also be collected, which will allow us to monitor the person's condition. We plan to monitor participants for at least two years. From these reports, we will be able determine to what extent tDCS is beneficial when done at home as a treatment for dementia symptoms.
Trial Details
NCT Number NCT04524338
Lead Sponsor Lady Davis Institute
Conditions Alzheimer Disease
Enrollment 20 participants
Start Date 2021-02-22
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-13